Daniel Chung
Chief Medical Officer of Beacon Therapeutics and ophthalmologist with over 30 years' experience in ocular gene therapy, including work on the development and approval of Luxturna and leadership on retinal gene-therapy programs.
Best podcasts with Daniel Chung
Ranked by the Snipd community
Feb 5, 2026 • 37min
EP 225: Lessons from 20 years of building ocular gene therapies with Daniel Chung of Beacon Therapeutics
Daniel Chung, an ophthalmologist and CMO with 30+ years in ocular gene therapy including work on Luxturna. He recounts building the first approved ocular gene therapy. They discuss designing pivotal trials, choosing meaningful clinical endpoints, delivery and immunogenicity challenges, and strategies for treating earlier patients and larger genes.
